SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Novell (NOVL) dirt cheap, good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Mark A. Forte who wrote (18967)12/8/1997 11:43:00 AM
From: Rich Young  Read Replies (2) | Respond to of 42771
 
That's probably the understatement of the year on this thread. Do you know of any reason why they would or are you just speculating? I can't see any reason why the same BOD would turn around less than a year later and rescind the poison pill, unless Schmidt, as chairman, has such influence over the GOB that he could sway them (no way in hell). He's one man against the world, as far as that goes.

RCY



To: Mark A. Forte who wrote (18967)12/8/1997 12:46:00 PM
From: Joe Antol  Respond to of 42771
 
Mark. That's the first real cogent analysis I've heard in a long time.
You are right on the money with that statement.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News